Femara More Effective Than Nolvadex
Scientists affiliated with the BIG-98 trial comparing Femaraandreg; (letrozole) to Nolvadexandreg; (tamoxifen) have reported that longer follow-up confirms the superiority of Femara in postmenopausal women with early, hormone-positive breast cancer. The details of this follow-up study were presented at the 2006 annual European Society for Medical Oncology (ESMO) meeting in Istanbul in October........
This entry was posted
on Wednesday, October 18th, 2006 at 4:46 pm and is filed under Nutritional facts.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.